Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lawrence D. Kaplan, MD
University of California, San Francisco
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Illinois Cancercare - Bloomington
Bloomington, Illinois, United States
- St. Joseph Medical Center
Bloomington, Illinois, United States
- Graham Hospital
Canton, Illinois, United States
- Illinois Cancercare - Canton
Canton, Illinois, United States
- Illinois Cancercare - Carthage
Carthage, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Eureka Community Hospital
Eureka, Illinois, United States
- Illinois Cancercare - Eureka
Eureka, Illinois, United States
- Galesburg Clinic, Pc
Galesburg, Illinois, United States
- Illinois Cancercare - Galesburg
Galesburg, Illinois, United States
- Illinois Cancercare - Havana
Havana, Illinois, United States
- Mason District Hospital
Havana, Illinois, United States
- Illinois Cancercare - Kewanee Clinic
Kewanee, Illinois, United States
- Illinois Cancercare - Macomb
Macomb, Illinois, United States
- Mcdonough District Hospital
Macomb, Illinois, United States
- Illinois Cancercare - Monmouth
Monmouth, Illinois, United States
- Osf Holy Family Medical Center
Monmouth, Illinois, United States
- Bromenn Regional Medical Center
Normal, Illinois, United States
- Community Cancer Center
Normal, Illinois, United States
- Illinois Cancercare - Community Cancer Center
Normal, Illinois, United States
- Community Hospital of Ottawa
Ottawa, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Ottawa
Ottawa, Illinois, United States
- Illinois Cancercare - Pekin
Pekin, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Methodist Medical Center of Illinois
Peoria, Illinois, United States
- Osf St. Francis Medical Center
Peoria, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Peoria
Peoria, Illinois, United States
- Proctor Hospital
Peoria, Illinois, United States
- Illinois Cancercare - Peru
Peru, Illinois, United States
- Illinois Valley Community Hospital
Peru, Illinois, United States
- Illinois Cancercare - Princeton
Princeton, Illinois, United States
- Perry Memorial Hospital
Princeton, Illinois, United States
- Illinois Cancercare - Spring Valley
Spring Valley, Illinois, United States
- Dana-Farber/brigham and Women'S Cancer Center
Boston, Massachusetts, United States
- Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 31 Dec 2013
- Completion
- 30 Jun 2022
- Last update posted
- 28 Oct 2025
- Registered enrollment
- 151
- Registry id
- NCT00310037
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.